Beso schreef op 20 september 2021 08:11:
[...]
Uiteraard hebben beiden schuld en dat is heel te betreuren.
Wat ik van dit verhaal opmerkelijk vond is :
How is this stock even under $0.20? It makes no sense, but the bear market for micro cap stocks knows no bottom thus far that we know of. It’s impossible to invent in OTC and penny stocks under $2 in such an environment. Relief’s recently completed acquisitions of APR Applied Pharma Research SA and AdVita Lifescience GmbH bring a diverse pipeline of marketed and development-stage programs. So this company is simply more mature than its current market cap would indicate.